Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
764.480.02%
QQQ
714.89-
BTC/USD
77240.010.0416%
DIA
525.910.02%
GLD
398.290.12%
TLT
80.930.07%

Anixa Biosciences Inc (ANIX) Stock Price, Quote, News & History

ANIXNASDAQ
Trade with Public
Trade with Public
$2.76
0.010.36%
At close: Sep 11, 5:00 PM EST
$2.79
0.02720.99%
After Hours: Sep 11, 5:32 PM EST
Earnings: Q3 2026 Earnings were released on Wed Sep 9th, after the market close
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Anixa Biosciences (ANIX) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$2.87
Close
$2.76
Volume / Avg.
389.37K / 285.96K
Day Range
$2.72 - $2.88
52 Wk Range
2.32 - 5.46
Market Cap
$96.89M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
31
Short Interest
3.01%
Days to Cover
3.33

Recent Anixa Biosciences Inc News

EXCLUSIVE: Anixa Biosciences' Ovarian Cancer Drug Candidate Shows Longer Survival With No Major Safety Issues

Anixa Biosciences shares new data from its ovarian cancer trial, showing patients lived longer than expected with no serious safety concerns, as regulators approved a major dose increase.
Vandana Singh

Anixa Biosciences Shares Jump Over 15% In After-Hours Trading — Here's Why

Anixa Biosciences shares surged in after-hours trading after presenting clinical trial data for its investigational breast cancer vaccine.
Mohd Haider

EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent

Anixa secures USPTO patent for its breast cancer vaccine using α-lactalbumin, enhancing its IP portfolio and expanding future immunotherapy options.
Vandana Singh

EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI Solutions To Develop AI-Guided Personalized Cancer Vaccines

Anixa Biosciences signed a letter of intent with VERDI Solutions to develop AI-powered personalized and off-the-shelf cancer vaccines, with U.S. trials planned.
Vandana Singh

EXCLUSIVE: Anixa Biosciences Poised To Receive US Patent For Ovarian Cancer Vaccine

Anixa Biosciences secured a USPTO patent allowance for its ovarian cancer vaccine, strengthening its IP position and advancing its clinical development.
Vandana Singh

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-7.38M
Investing Cash Flow (TTM)
2.06M
Financing Cash Flow (TTM)
5.22M
Free Cash Flow (TTM)
-7.38M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-97.00K

Analyst Trends and Forecast

1
Mar
1
Apr
1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$82.08M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
6.58
Earnings Yield % (TTM)
-11.68%
Earnings Yield % (FWD)
-12.04%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.42

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$1.40M
Debt to Equity
0.01
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$2.87
Close
$2.76
Volume / Avg.
389.37K / 285.96K
Day Range
$2.72 - $2.88
52 Wk Range
2.32 - 5.46
Market Cap
$96.89M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
31
Short Interest
3.01%
Days to Cover
3.33

About

Sector
Health Care
Industry
Biotechnology
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer V...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Anixa Biosciences (ANIX) stock?

A

You can purchase shares of Anixa Biosciences (NASDAQ:ANIX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Anixa Biosciences (ANIX) competitors?

Q

What is the forecast, or price target, for Anixa Biosciences (ANIX) stock?

A

Anixa Biosciences has a consensus price target of $9.20.

Q

What is the current price for Anixa Biosciences (ANIX)?

A

The stock price for Anixa Biosciences (NASDAQ: ANIX) is $2.7872 last updated September 11, 2026 at 5:32 PM EDT.

Q

Does Anixa Biosciences (ANIX) pay a dividend?

A

There are no upcoming dividends for Anixa Biosciences.

Q

When is Anixa Biosciences (NASDAQ:ANIX) reporting earnings?

A

Anixa Biosciences does not have any upcoming earnings scheduled.

Q

Is Anixa Biosciences (ANIX) going to split?

A

There is no upcoming split for Anixa Biosciences.

Q

What sector and industry does Anixa Biosciences (ANIX) operate in?

A

Anixa Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved